Assessment of bronchial hyperreactivity, maximal airway response and response to inhaled corticosteriod treatment in patients with bronchiectasis Source: Annual Congress 2007 - Current issues in airway physiology, pharmacology and monitoring Year: 2007
The association between airway and systemic eosinophilia and symptoms and exacerbations differ between asthma and COPD patients Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling Year: 2020
Heterogeneous response of airway eosinophilia to biologics in severe asthma patients Source: Virtual Congress 2021 – Advances in asthma treatment: monoclonal antibodies Year: 2021
The lung microcirculation changes in patients with bronchial asthma Source: Eur Respir J 2006; 28: Suppl. 50, 407s Year: 2006
Same role and same treatment for airway eosinophilia in asthma and COPD? Source: Eur Respir J 2007; 29: 831-833 Year: 2007
Involvement of airway eosinophilia and airway hyperresponsiveness in management and therapy for COPD> Source: Virtual Congress 2020 – Clinical studies of COPD: combination inhalers and much more Year: 2020
Influence of large and small dose of fluticasone propionate on clinical symptoms of bronchial asthma, lung function, bronchial hyperreactivity and eosinophilia in induced sputum Source: Eur Respir J 2002; 20: Suppl. 38, 111s Year: 2002
Severe exacerbations, decline in lung function and inhaled budesonide in asthma Source: Eur Respir J 2007; 30: Suppl. 51, 619s Year: 2007
Monitoring asthma in children: lung function, bronchial hyperresponsiveness and inflammation Source: International Congress 2014 – Monitoring asthma in children: results of the ERS Task Force Year: 2014
The influence of obesity on bronchial hyperresponsiveness, airway and systemic inflammation, lung function and quality of life in patients with asthma Source: Annual Congress 2008 - Asthma: growing understanding of influential factors Year: 2008
Maximal airway response in patients with asthma and cough variant asthma Source: Annual Congress 2007 - COPD, sarcoidosis, idiopathic pulmonary fibrosis, cystic fibrosis, gastro-oesophageal reflux and cough variant asthma - pathogenesis and differential diagnosis Year: 2007
Monitoring asthma in childhood: lung function, bronchial responsiveness and inflammation Source: Eur Respir Rev 2015; 24: 204-215 Year: 2015
Omalizumab therapy reduces asthma exacerbations in children with severe allergic (IgE-mediated) asthma irrespective of lung function at baseline Source: Annual Congress 2009 - Difficult asthma in children: diagnostic and therapeutic challenges Year: 2009
Bronchial responsiveness, lung function and induced sputum eosinophilia in outgrown childhood asthma Source: Eur Respir J 2004; 24: Suppl. 48, 587s Year: 2004
Monitoring of pediatric asthma by symptoms and lung function versus symptoms, lung function and exhaled NO Source: Annual Congress 2004 - Monitoring childhood asthma Year: 2004
The glucocorticoid therapy influence on the lung microcirculation in patients with bronchial asthma Source: Eur Respir J 2005; 26: Suppl. 49, 353s Year: 2005
Dose reduction of inhaled corticosteroids under concomitant medication with montelukast in patients with asthma Source: Eur Respir J 2002; 20: 1080-1087 Year: 2002
Analysis of airway inflammation in allergic subjects with asymptomatic increased airway response to methacholine Source: Eur Respir J 2006; 28: Suppl. 50, 678s Year: 2006
Seasonal fluctuations in lung function and asthma control in patients with airway osmotic hyperresponsiveness Source: Virtual Congress 2020 – Clinical and functional evaluation of asthmatics Year: 2020
Dissociation in effects of fluticasone but not fluticasone/salmeterol on lung function and airway hyperresponsiveness in mild persistent asthma Source: Eur Respir J 2002; 20: Suppl. 38, 385s Year: 2002